FDA recall, , Moderate risk
Remel Yeastone Broth
Yeastone Broth may report incorrect AST results during quality control, potentially causing delayed response or need to change antifungal agent.
Summary by Recall Canary from the FDA notice
What happened
Remel, Inc of Lenexa, Kansas began a recall on March 24, 2026 for Yeastone Broth, 11ML, 10/BOX YY3462. The FDA added the product to its Enforcement Report on April 10, 2026, and classified it the same day.
The product may report incorrect AST results during quality control, and health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result. The recall was listed in the FDA's weekly enforcement report on April 22, 2026.
Distribution was worldwide, including the US Nationwide and the countries of Canada, Vietnam, France, Argentina, Qatar, New Zealand, Uruguay, Turkey, Netherlands, Singapore.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is your box affected?
Match the UDI-DI and lot code listed under your product.
A UDI-DI is the device identifier printed with the barcode on the device label.
Yeastone Broth, 11ML, 10/Box YY3462
- UDI-DI
- 848838018817
- Lot code
- 321046
- 329835
- 330316
- 327069
- 330317
- 336325
- 338314
- 341161
- 303851
- 311723
Recall details
- Company began the recall
- Sold in
Worldwide distribution - US Nationwide and the countries of Canada, Vietnam, France, Argentina, Qatar, New Zealand, Uruguay, Turkey, Netherlands, Singapore.
- Company
- Remel, IncLenexa, Kansas
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98616
- Recall number
- Z-1806-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated
